PHARMCO II ApS: Financial statements 2018
CVR: 25202899
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
PHARMCO II ApS (CVR 25202899) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -18,749 and a net result of DKK 1,682,250 compared with DKK 2,785,070 the year before. Equity in the 2018 report amounted to DKK 61,177,919. The solvency ratio was 88.5%.
- Gross Profit
- DKK -18,749
- Profit/Loss
- DKK 1,682,250
- Equity
- DKK 61,177,919
- Total Assets
- DKK 69,141,343
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -19 t. | 1.7 mio. | 61.2 mio. | - |
| 2017 | - | -18 t. | 2.8 mio. | 59.5 mio. | - |
| 2016 | - | -21 t. | 2.3 mio. | 56.7 mio. | - |
| 2015 | - | 17.8 mio. | 3 mio. | - | 37 |
| 2014 | - | -21 t. | 1.8 mio. | 52.8 mio. | 34 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
PHARMCO II ApS has published its annual report for 2017. Gross profit came to DKK -18,126, and the net result was DKK 2,785,070.
About PHARMCO II ApS
PHARMCO II ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 2000. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Eli Wallin. The company is owned by Eli Wallin and PharmCo III ApS. According to the 2025 annual report, the company had an average of 66 employees. In 2025, the company reported a gross profit of DKK -56,000 and a net result of DKK 34,432,000 compared with DKK 7,096,622 the year before. Equity in the 2025 report amounted to DKK 107,079,000.